Article
Hepatitis C virus replication fitness as a determinant of antiviral therapy outcome
2026-02-04
Abstract excerpt
<h4>Background and Aims</h4> Hepatitis C virus (HCV) infections were previously treated with interferon (IFN) but today direct acting antivirals (DAAs) with cure rates >95% are available. DAA treatment failure is primarily attributed to resistance associated mutations (RAMs), often imposing a fitness cost. Interferon treatment outcome was shown to be associated with the interferon sensitivity determining region (...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c1c90370-99c2-5874-8ccf-97646b956b99
- DOI
- 10.64898/2026.02.03.703674
